Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Braz. J. Pharm. Sci. (Online) ; 59: e19978, 2023. tab
Article in English | LILACS | ID: biblio-1429949

ABSTRACT

Abstract Propolis is a resinous hive product collected by bees from the buds or other parts of plants. It is known for having various biological properties, including antifungal activity. Among the substances present in propolis, flavonoids and phenolic acids and their esters are responsible for its antifungal properties. This means that propolis is ideal for use as an antifungal agent in alternative medicine to treat a number of both topical and systemic infections caused by Candida species and other yeast-like fungi, dermatophyte and nondermatophyte moulds, without the serious side effects typical of synthetic treatment. It is also active against strains of fungi that are resistant to polyenes and azoles, the classes of drugs most commonly used to treat fungal infections. In this article, we review current knowledge about the activity of propolis from different parts of the world and its components in vitro and in vivo against pathogenic fungi isolated from human infections. The article also indicates the possible mechanism of antifungal activity of propolis and its components.


Subject(s)
Propolis/adverse effects , Antifungal Agents/analysis , In Vitro Techniques/methods , Complementary Therapies/classification , Candida/classification , Pharmaceutical Preparations/administration & dosage , Arthrodermataceae/classification
2.
Braz. j. microbiol ; 43(1): 274-282, Jan.-Mar. 2012. ilus, tab
Article in English | LILACS | ID: lil-622814

ABSTRACT

A total of 62 Pseudomonas aeruginosa strains isolated from two hospitals in Siedlce (Poland) were studied by repetitive element based PCR (rep-PCR) using BOX primer. BOX-PCR results revealed the presence of 7 numerous genotypes and 31 unique patterns among isolates. Generally, the strains of P. aeruginosa were characterized by resistance to many antibiotics tested and by differences in serogroups and types of growth on cetrimide agar medium. However, the P. aeruginosa strains isolated from faeces showed much lower phenotypic and genotypic variations in comparison with strains obtained from other clinical specimens. It was observed that genetic techniques supported by phenotypic tests have enabled to conduct a detailed characterization of P. aeruginosa strains isolated from a particular environment at a particular time.


Subject(s)
Humans , Diagnostic Techniques and Procedures , Drug Resistance, Microbial , Genetic Techniques , Genetics, Microbial , Phenotype , Pseudomonas Infections , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification , Genotype , Immunity, Innate , Methods , Patients , Serotyping
SELECTION OF CITATIONS
SEARCH DETAIL